A detailed history of Jefferies Financial Group Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 400,000 shares of BHC stock, worth $3.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
400,000
Previous 350,000 14.29%
Holding current value
$3.39 Million
Previous $2.44 Million 33.66%
% of portfolio
0.02%
Previous 0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.22 - $8.26 $261,000 - $413,000
50,000 Added 14.29%
400,000 $3.26 Million
Q2 2024

Aug 13, 2024

BUY
$6.1 - $10.41 $1.85 Million - $3.16 Million
303,400 Added 651.07%
350,000 $2.44 Million
Q1 2024

May 13, 2024

SELL
$7.77 - $10.61 $1.97 Million - $2.69 Million
-253,400 Reduced 84.47%
46,600 $494,000
Q4 2023

Feb 13, 2024

SELL
$6.53 - $8.23 $1.31 Million - $1.65 Million
-200,000 Reduced 40.0%
300,000 $2.41 Million
Q3 2023

Nov 14, 2023

SELL
$7.69 - $9.71 $23.1 Million - $29.1 Million
-3,000,000 Reduced 85.71%
500,000 $4.11 Million
Q2 2023

Aug 14, 2023

SELL
$5.72 - $8.8 $10.6 Million - $16.3 Million
-1,850,000 Reduced 34.58%
3,500,000 $28 Million
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $27.9 Million - $43.8 Million
4,443,942 Added 490.47%
5,350,000 $43.3 Million
Q4 2022

Sep 21, 2023

SELL
$6.09 - $7.93 $15.8 Million - $20.6 Million
-2,593,942 Reduced 74.11%
906,058 $5.69 Million
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $5.52 Million - $7.19 Million
906,058 New
906,058 $5.69 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.